Mold prompts recall of 5,000 vials of J&J's Risperdal Consta

Johnson & Johnson recalled an estimated 5,000 of the 70,000 vials of antipsychotic drug Risperdal Consta manufactured in one lot last year after testing positive for Alternaria alternata mold during routine quality inspection. The products must be pulled because they remain unused in pharmacies, community mental health centers and doctor's offices.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ